Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

BOSTON SCIENTIFIC CORPORATION

(BSX)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/09/2019 09/10/2019 09/11/2019 09/12/2019 09/13/2019 Date
41.74(c) 41.3(c) 42.3(c) 42.24(c) 41.81(c) Last
6 171 451 10 912 248 6 370 370 5 676 761 4 535 393 Volume
-3.94% -1.05% +2.42% -0.14% -1.02% Change
More quotes
Financials (USD)
Sales 2019 10 686 M
EBIT 2019 2 759 M
Net income 2019 1 409 M
Debt 2019 8 293 M
Yield 2019 -
Sales 2020 11 828 M
EBIT 2020 3 149 M
Net income 2020 2 003 M
Debt 2020 5 502 M
Yield 2020 -
P/E ratio 2019 42,8x
P/E ratio 2020 30,6x
EV / Sales2019 6,23x
EV / Sales2020 5,39x
Capitalization 58 240 M
More Financials
Company
Boston Scientific specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (62.7%): products used in cardiology surgeries (42.6% of net sales), cardiac rhythm management (33.4%), peripheral... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
09/13BOSTON SCIENTIFIC : Connecting the Dots of Innovation with Inspiration from Our ..
PU
09/13BOSTON SCIENTIFIC : Trailblazing STEM Skills
PU
09/11BOSTON SCIENTIFIC : Switching Lanes to Drive Innovation
PU
09/05BOSTON SCIENTIFIC : SAP-Attending SuccessConnect? Tips from a Customer Attendee
AQ
09/03BOSTON SCIENTIFIC : Description Statement of Changes in Beneficial Ownership
PU
08/28BOSTON SCIENTIFIC : Celebrates 15th Anniversary in Costa Rica
PU
08/22BOSTON SCIENTIFIC : Empowering Female Business Leaders in Asia Pacific
PU
08/20BOSTON SCIENTIFIC : to Participate in the 2019 Wells Fargo Securities Healthcare..
PR
08/19BOSTON SCIENTIFIC : Announces FDA Approval Of ImageReady™ MRI For Vercise ..
PR
08/19BOSTON SCIENTIFIC : Description Statement of Changes in Beneficial Ownership
PU
More news
Analyst Recommendations on BOSTON SCIENTIFIC CORPORAT
More recommendations
Sector news : Advanced Medical Equipment & Technology - NEC
09/11Dutch government to trim multinational tax deductions - NOS
RE
09/11GE Cuts Baker Hughes Stake -- WSJ
DJ
09/10Google, Amazon and Microsoft in Battle to Store Health Data in the Cloud
DJ
09/06NO PLACE LIKE HOME : Chinese firms stung by trade war build up domestic brands
RE
08/29SONY : in $760 million Olympus stake sale after investor Loeb's prodding
RE
More sector news : Advanced Medical Equipment & Technology - NEC
Chart BOSTON SCIENTIFIC CORPORATION
Duration : Period :
Boston Scientific Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Average target price 47,22  $
Last Close Price 41,81  $
Spread / Highest target 26,8%
Spread / Average Target 12,9%
Spread / Lowest Target -35,4%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
John Bradley Sorenson Senior Vice President-Manufacturing & Supply Chain
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION18.31%58 240
THERMO FISHER SCIENTIFIC33.00%119 202
DANAHER CORPORATION36.75%101 163
INTUITIVE SURGICAL9.25%60 303
EDWARDS LIFESCIENCES CORPORATION43.30%45 649
ILLUMINA, INC.0.33%44 234